Enerpac Tool
EPAC
Precision Drilling
PDS
Halozyme Therapeutics
HALO
4
Workday
WDAY
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 71.90%-2.91M | -3.55%-845K | 68.20%-449K | 75.76%-1.17M | 86.44%-450K | 70.95%-10.36M | 88.79%-816K | 78.44%-1.41M | 47.00%-4.81M | 73.99%-3.32M |
Net income from continuing operations | 42.65%-9.7M | -382.92%-7.18M | 79.24%-1.09M | 89.59%-600K | 81.19%-829K | -555.07%-16.91M | -108.08%-1.49M | -1.86%-5.26M | 22.84%-5.76M | 47.21%-4.41M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | --920K | --0 | ---- | ---- | ---- |
Depreciation and amortization | -40.07%824K | 7.61%212K | -37.91%208K | -50.73%203K | -53.36%201K | -25.92%1.38M | -56.99%197K | -27.80%335K | -11.02%412K | -8.49%431K |
Other non cash items | ---407K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 15,000.00%149K | -121.17%-105K |
Change In working capital | -30.96%631K | 77.48%804K | -26.42%429K | -34.32%-775K | -61.98%173K | 102.48%914K | 101.72%453K | 127.13%583K | 77.60%-577K | 107.96%455K |
-Change in receivables | ---506K | --829K | ---791K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Change in prepaid assets | 33.29%977K | -39.24%370K | 1,014.29%192K | 1,741.67%197K | 38.85%218K | -75.98%733K | 680.77%609K | -102.16%-21K | -104.41%-12K | -90.91%157K |
-Change in payables and accrued expense | 13.32%987K | -161.25%-177K | 57.22%1.24M | 54.02%-229K | -47.93%151K | 110.57%871K | 112.58%289K | 181.87%790K | -104.10%-498K | 106.13%290K |
-Change in other current assets | --0 | --0 | --0 | --0 | --0 | 101.76%38K | 88.57%-253K | -87.50%3K | 440.00%108K | 4,400.00%180K |
-Change in other current liabilities | -13.60%-827K | -13.54%-218K | -13.23%-214K | -13.71%-199K | -13.95%-196K | -14.29%-728K | -14.29%-192K | -13.86%-189K | -14.38%-175K | -14.67%-172K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 71.90%-2.91M | -3.55%-845K | 68.20%-449K | 75.76%-1.17M | 86.44%-450K | 70.95%-10.36M | 88.79%-816K | 78.44%-1.41M | 47.00%-4.81M | 73.99%-3.32M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | -122.96%-1.08M | 243.48%711K | 0 | -226.67%-1.9M | -94.69%106K |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | 349.76%922K | 246.83%711K | --0 | --105K | --106K |
Net investment purchase and sale | --0 | --0 | --0 | ---- | ---- | -144.43%-2M | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | --0 | --0 | -122.96%-1.08M | 243.48%711K | --0 | -226.67%-1.9M | -94.69%106K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 264.78%13.4M | 1,240,300.00%12.4M | 0 | 208.81%1M | 0 | 218.33%3.67M | -1K | 50.00%-1K | -118.79%-919K | 157.49%4.6M |
Net issuance payments of debt | --1M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net common stock issuance | 127.98%12.4M | --12.4M | --0 | --0 | --0 | 7.94%5.44M | --0 | --0 | --0 | --5.44M |
Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | -4,310.53%-800K | --0 | --0 | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -45.48%-966K | ---1K | 50.00%-1K | 23.23%-119K | -66.67%-845K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 264.78%13.4M | 1,240,300.00%12.4M | --0 | 208.81%1M | --0 | 218.33%3.67M | ---1K | 50.00%-1K | -118.79%-919K | 157.49%4.6M |
Net cash flow | ||||||||||
Beginning cash position | -79.38%2.02M | -55.18%951K | -60.40%1.4M | -85.97%1.57M | -79.38%2.02M | -77.70%9.78M | -87.40%2.12M | -84.22%3.54M | -55.52%11.16M | -77.70%9.78M |
Current changes in cash | 235.19%10.49M | 11,002.83%11.56M | 68.22%-449K | 97.82%-166K | -132.54%-450K | 77.22%-7.76M | 98.50%-106K | 74.55%-1.41M | -183.25%-7.63M | 107.37%1.38M |
End cash Position | 520.44%12.51M | 520.44%12.51M | -55.18%951K | -60.40%1.4M | -85.97%1.57M | -79.38%2.02M | -79.38%2.02M | -87.40%2.12M | -84.22%3.54M | -55.52%11.16M |
Free cash flow | 71.90%-2.91M | -3.55%-845K | 68.20%-449K | 75.76%-1.17M | 86.44%-450K | 70.96%-10.36M | 88.79%-816K | 78.44%-1.41M | 47.03%-4.81M | 74.00%-3.32M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |